ErbB2/HER2: Its Contribution to Basic Cancer Biology and the Development of Molecular Targeted Therapy

QR Code

ErbB2/HER2: Its Contribution to Basic Cancer Biology and the Development of Molecular Targeted Therapy

None

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Yamamoto, Tadashi, Saito, Makoto, Kumazawa, Kentaro, Doi, Ayano, Matsui, Atsuka, Takebe, Shiori, Amari, Takuya, Oyama, Masaaki, Semba, Kentaro
Format:	Électronique Chapitre de livre
Langue:	anglais
Publié:	IntechOpen 2011
Sujets:	Health Sciences
Accès en ligne:	https://www.intechopen.com/chapters/23372
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Clinicopathological value of ErbB2 gene and protein expression in osteochondroma
par: Zhen Huang, et autres
Publié: (2020-01-01)

The Role of ErbB Receptors in Endometrial Cancer
par: Georgios, Adonakis, et autres
Publié: (2012)

Neuregulin1-ErbB Signaling in Doxorubicin-Induced Cardiotoxicity
par: Goukassian, David, et autres
Publié: (2012)

Mapping of an epitope of ErbB-2 for recognizing by monoclonal antibody 4B8 using phage display technolog
par: M. B. Borgoyakova, et autres
Publié: (2016-02-01)

Integrin-Mediated Endothelial Cell Adhesion and Activation of c-Src, EGFR and ErbB2 are Required for Endothelial-Mesenchymal Transition
par: Arciniegas, Enrique, et autres
Publié: (2011)

Vitamin D ameliorates prediabetic cardiac injure via modulation of the ErbB4/ferroptosis signaling axis
par: Yufan Miao, et autres
Publié: (2025-07-01)

Exploring the Effects of Acupuncture on Behaviors of Autism Spectrum Disorder Based on the NRG1/ErbB4 Signaling Pathway
par: ZHUANG Wanyu, et autres
Publié: (2025-02-01)

Assessment of <i>ERBB2</i> and HER2 expression in metastatic breast cancer using the nCounter® system and a 100-gene scale
par: R. M. Paltuev, et autres
Publié: (2023-10-01)

ИССЛЕДОВАНИЕ ЭФФЕКТИВНОСТИ ИНДУКЦИИ ЦИТОТОКСИЧЕСКОГО ИММУННОГО ОТВЕТА МОНОНУКЛЕАРНЫМИ КЛЕТКАМИ С ПОМОЩЬЮ ДЕНДРИТНЫХ КЛЕТОК, ТРАНСФЕЦИРОВАННЫХ ПОЛИЭПИТОПНЫМИ КОНСТРУКЦИЯМИ HER2/ERBB2
par: A. Z. Maksyutov, et autres
Publié: (2014-11-01)

Differences in the distribution of HER2-positive breast tumors according to ethnicity and genetic variants in ERBB2: a special focus on Asian and Latina women
par: Laura Rey-Vargas, et autres
Publié: (2025-07-01)

NGS coverage accurately predicts MET and HER2 (ERBB2) gene amplifications in a real-world non-small cell lung cancer cohort
par: Adam Kowalewski, et autres
Publié: (2025-07-01)

Roles of Microtubules in Maintenance of Nerve Cell Networks
par: Yomogida, Kentaro, et autres
Publié: (2011)

Potential Resistance to Oxaliplatin-Based Regimens in Gastric Cancer Patients with ERBB2 R678Q Mutation: Evidence from a National Genomic Database
par: Shuhei Suzuki, et autres
Publié: (2025-06-01)

Random Insertion Reporter Gimmicks Powered by Cut-and-Paste DNA Transposons
par: Yamato Kasahara, et autres
Publié: (2025-07-01)

Seelsorge als Denkdiakonie. Reformatorisches Erbe in der heutigen Seelsorge
par: Dávid NÉMETH
Publié: (2017-12-01)

STUDY OF THE EFFECT OF LOMUSTIN ON HER2-POSITIVE BREAST CANCER IN FVB/N HER-2 TRANSGENIC MICE
par: A. N. Stukov, et autres
Publié: (2019-11-01)

Modulation of HER2 internalization enhances single-dose antibody-drug potency in HER2+ gastric cancer
par: Abbey Zidel, et autres
Publié: (2025-05-01)

Clinical Outcomes of CDK4/6 Inhibitor Therapy in HR+/HER2− Metastatic Breast Cancer: A Multicenter Comparison of HER2-Low and HER2-Zero Subgroups
par: Erkan Ozcan, et autres
Publié: (2025-01-01)

Improving treatment outcomes for patients with HER2‑positive breast cancer using neoadjuvant double HER2 blockade
par: V. F. Semiglazov, et autres
Publié: (2024-11-01)

Capivasertib/Fulvestrant in patients with HR+, HER2-low or HER2-negative locally advanced or metastatic breast cancer
par: Karam Aboud, et autres
Publié: (2025-07-01)

Efficacy and Safety of HER2-Targeted Agents for Breast Cancer with HER2-Overexpression: A Network Meta-Analysis.
par: Qiuyan Yu, et autres
Publié: (2015-01-01)

Specific antibodies and sensitive immunoassays for the human epidermal growth factor receptors (HER2, HER3, and HER4)
par: Marianne Nordlund Broughton, et autres
Publié: (2017-06-01)

Temperature dependence of barrier height in a Ni/β-Ga2O3 Schottky barrier diode precisely determined by the analysis based on the thermionic emission-diffusion model
par: Akihira Munakata, et autres
Publié: (2025-01-01)

HER-2 Signaling in Human Breast Cancer
par: Ignatoski, Kathleen M. Woods
Publié: (2011)

Pathologic Response and Survival Outcomes on HER2-Low vs. HER2-Zero in Breast Cancer Receiving Neoadjuvant Chemotherapy
par: Rumeysa Colak, et autres
Publié: (2025-06-01)

Serum HER2 Is a Potential Surrogate for Tissue HER2 Status in Gastric Cancer: A Systematic Review and Meta-Analysis.
par: Kecheng Zhang, et autres
Publié: (2015-01-01)

Fourth Swiss Annual Meeting on HER2-Positive Breast Cancer: Antibody-Drug Conjugates in HER2-Positive Disease and Beyond
par: Marcus Vetter, et autres
Publié: (2025-06-01)

Targeting EGFR and HER2 for Molecular Imaging of Cancer
par: Gong, Haibiao, et autres
Publié: (2012)

Extracellular domain of HER2 heterologous expression in bacteria
par: V. V. Dolgikh, et autres
Publié: (2013-12-01)

Immunomorphological specifcity of HER2-low breast cancer
par: I. V. Mikhailov, et autres
Publié: (2024-11-01)

Mixed adenoneuroendocrine carcinoma with loss of HER2 positivity after trastuzumab-based chemotherapy for HER2-positive gastric cancer: a case report
par: Hiromi Nagata, et autres
Publié: (2020-01-01)

A novel bispecific aptamer targeting LAG3 and HER2 enhances T cell-mediated immunotherapy against HER2-positive cancer cells
par: Rui Guo, et autres
Publié: (2025-07-01)

The Electronics of HER2/neu Positive Breast Cancer Cells
par: Baumann, Jan, et autres
Publié: (2011)

Targeting HER-2 Signaling Network: Implication in Radiation Response
par: Kim, In Ah
Publié: (2011)

POSSIBILITIES OF THERAPY OF HER-2-POSITIVE REGIONAL BREAST CANCER
par: A. S. Belokhvostova, et autres
Publié: (2015-04-01)

Present and future of breast cancer anti-Her-2-therapy
par: V. P. Letyagin
Publié: (2014-07-01)

Target therapy in treatment of HER2-positive breast cancer
par: A. S. Belokhvostova, et autres
Publié: (2016-02-01)

Prevalence and Clinicopathologic Features of HER2 Overexpression in Endocervical Adenocarcinoma
par: Niusha Momeni, et autres
Publié: (2025-07-01)

Assessment of ESR1, PGR, ERBB2, and MKI67 mRNA in Hormone Receptor‐Positive Early Breast Cancer: A Cross‐Sectional Study
par: Hamid Rezvani, et autres
Publié: (2025-07-01)

Novel Therapeutic Strategies and Combinations for HER2-Overexpressing Breast Cancer
par: Shabaya, Sylvia, et autres
Publié: (2011)